United States Pharmaceuticals

Cadrenal Therapeutics Inc (CVKD)

Track

Track

Cadrenal Therapeutics Inc. experienced significant insider trading activity recently, characterized exclusively by planned sales from Chairman and CEO Pham Quang X. These divestments occurred amidst a 65.8% decline in stock value over the past quarter. No purchase orders were recorded, reflecting a consistent pattern of liquidation by leadership following the latest results financiers.
Ticker: CVKD Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cadrenal Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
Pham Quang X Chairman and CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
371.64
Quantity 38,296 +37.2%
Value US$4,080,334
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
313.67
Quantity 80,659 +18.4%
Value US$4,866,368
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
30.94
Quantity 8,107 +41.2%
Value US$200,189
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.20
Quantity 2,277 -1.9%
Value US$7,286
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.55
Quantity 9,167 -7.1%
Value US$32,543
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.16
Quantity 513 -0.4%
Value US$1,621
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.18
Quantity 3,613 -2.7%
Value US$11,489
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.58
Quantity 3,666 -2.7%
Value US$13,124
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
3.71
Quantity 40,000
Value US$148,400
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.94
Quantity 12,996 -8.7%
Value US$51,204
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.12
Quantity 1,462 -1.0%
Value US$6,023
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.21
Quantity 3,500 -2.3%
Value US$14,735
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.21
Quantity 3,500 -2.3%
Value US$14,735
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.06
Quantity 12,992 -7.8%
Value US$52,748
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.06
Quantity 12,992 -7.8%
Value US$52,748
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.38
Quantity 5,893 -3.4%
Value US$25,811
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
4.42
Quantity 2,064 -1.2%
Value US$9,123
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
4.41
Quantity 3,898 -2.2%
Value US$17,190
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
4.26
Quantity 2,323 -1.3%
Value US$9,896
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
4.46
Quantity 349 -0.2%
Value US$1,557
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
5.01
Quantity 303 -0.2%
Value US$1,518
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
4.93
Quantity 2,989 -1.6%
Value US$14,736
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
5.69
Quantity 1,165 -0.6%
Value US$6,629
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
5.28
Quantity 3,298 -1.8%
Value US$17,413
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
5.76
Quantity 6,476 -3.3%
Value US$37,302
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
5.81
Quantity 60,000
Value US$348,600
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.97
Quantity 9,933 -100.0%
Value US$69,233
2.3
MATTHEW K SZOT Officer Officer
Transaction date
Proposed sale
Price
7.41
Quantity 9,933
Value US$73,604
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.99
Quantity 1,800 -15.3%
Value US$25,182
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
13.99
Quantity 1,315 -0.7%
Value US$18,397
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
14.13
Quantity 1,800
Value US$25,442
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
13.99
Quantity 1,315
Value US$18,397
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.99
Quantity 1,800 -13.3%
Value US$25,182
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.03
Quantity 1,129 -0.6%
Value US$15,840
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.77
Quantity 1,800
Value US$24,786
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.03
Quantity 1,129
Value US$15,841
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.62
Quantity 1,800
Value US$24,516
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.15
Quantity 1,800
Value US$25,470
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.15
Quantity 1,800 -0.9%
Value US$25,470
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.07
Quantity 1,800 -11.7%
Value US$25,326
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.02
Quantity 1,800 -0.9%
Value US$25,236
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.99
Quantity 1,693 -9.9%
Value US$23,685
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.96
Quantity 1,693
Value US$23,634
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.02
Quantity 1,800
Value US$25,228
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.99
Quantity 107 -0.6%
Value US$1,497
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
14.18
Quantity 107
Value US$1,517
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.13
Quantity 500 -0.2%
Value US$7,065
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.13
Quantity 500
Value US$7,066
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.83
Quantity 1,700
Value US$23,511
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.01
Quantity 881
Value US$12,343
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.01
Quantity 881 -0.4%
Value US$12,343
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.99
Quantity 1,700 -9.0%
Value US$23,783
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.01
Quantity 419 -0.2%
Value US$5,870
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.00
Quantity 100 -0.5%
Value US$1,400
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
14.03
Quantity 100
Value US$1,403
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.01
Quantity 419
Value US$5,870
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.09
Quantity 6,790
Value US$95,662
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Sale
Price
14.09
Quantity 6,790 -3.2%
Value US$95,671
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Sale
Price
14.05
Quantity 10,900 -36.5%
Value US$153,182
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.78
Quantity 10,900
Value US$150,202
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Sale
Price
13.99
Quantity 2,581 -1.2%
Value US$36,108
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Sale
Price
14.00
Quantity 1,500 -4.8%
Value US$20,993
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.09
Quantity 6,790
Value US$95,662
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.68
Quantity 1,500
Value US$20,520
2.8
Quang Pham Officer Officer
Transaction date
Proposed sale
Price
13.99
Quantity 2,581
Value US$36,108
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Sale
Price
13.99
Quantity 1,193 -0.6%
Value US$16,690
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Sale
Price
14.00
Quantity 400 -1.3%
Value US$5,600
2.8
Pham Quang X Officer Officer
Transaction date
Proposed sale
Price
13.86
Quantity 1,193
Value US$16,541
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.93
Quantity 400
Value US$5,572
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Sale
Price
13.99
Quantity 3,836 -1.8%
Value US$53,666
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Sale
Price
14.00
Quantity 1,600 -4.8%
Value US$22,392
2.8
Pham Quang X Officer Officer
Transaction date
Proposed sale
Price
13.94
Quantity 3,836
Value US$53,456
2.8
Pham Quang X Officer Officer
Transaction date
Proposed sale
Price
13.99
Quantity 30,600
Value US$428,094
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.75
Quantity 1,600
Value US$22,000
2.8
MURPHY JOHN RAYMOND Non-Executive Director
Transaction date
Purchase
Price
0.69
Quantity 2,669 +0.4%
Value US$1,842
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-01 2026-06-29 PlS Planned sale
2.8
Pham Quang X

Chairman and CEO

Executive Director Large shareholder
38,296 +37.2%
371.64
US$4,080,334 		38,296 +37.2% 371.64 US$4,080,334
2026-06-26 2026-06-26 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
80,659 +18.4%
313.67
US$4,866,368 		80,659 +18.4% 313.67 US$4,866,368
2026-06-26 2026-06-25 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
8,107 +41.2%
30.94
US$200,189 		8,107 +41.2% 30.94 US$200,189
2026-06-24 2026-06-23 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
2,277 -1.9%
3.20
US$7,286 		2,277 -1.9% 3.20 US$7,286
2026-06-24 2026-06-22 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
9,167 -7.1%
3.55
US$32,543 		9,167 -7.1% 3.55 US$32,543
2026-06-18 2026-06-17 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
513 -0.4%
3.16
US$1,621 		513 -0.4% 3.16 US$1,621
2026-06-18 2026-06-16 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
3,613 -2.7%
3.18
US$11,489 		3,613 -2.7% 3.18 US$11,489
2026-06-15 2026-06-15 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
3,666 -2.7%
3.58
US$13,124 		3,666 -2.7% 3.58 US$13,124
2026-06-15 2026-06-15 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
40,000
3.71
US$148,400 		40,000 3.71 US$148,400
2026-06-15 2026-06-12 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
12,996 -8.7%
3.94
US$51,204 		12,996 -8.7% 3.94 US$51,204
2026-06-15 2026-06-11 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
1,462 -1.0%
4.12
US$6,023 		1,462 -1.0% 4.12 US$6,023
2026-06-10 2026-06-10 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
3,500 -2.3%
4.21
US$14,735 		3,500 -2.3% 4.21 US$14,735
2026-06-10 2026-06-10 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
3,500 -2.3%
4.21
US$14,735 		3,500 -2.3% 4.21 US$14,735
2026-06-10 2026-06-09 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
12,992 -7.8%
4.06
US$52,748 		12,992 -7.8% 4.06 US$52,748
2026-06-10 2026-06-09 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
12,992 -7.8%
4.06
US$52,748 		12,992 -7.8% 4.06 US$52,748
2026-06-10 2026-06-08 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
5,893 -3.4%
4.38
US$25,811 		5,893 -3.4% 4.38 US$25,811
2026-06-05 2026-06-05 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
2,064 -1.2%
4.42
US$9,123 		2,064 -1.2% 4.42 US$9,123
2026-06-05 2026-06-04 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
3,898 -2.2%
4.41
US$17,190 		3,898 -2.2% 4.41 US$17,190
2026-06-05 2026-06-03 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
2,323 -1.3%
4.26
US$9,896 		2,323 -1.3% 4.26 US$9,896
2026-06-02 2026-06-02 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
349 -0.2%
4.46
US$1,557 		349 -0.2% 4.46 US$1,557
2026-06-02 2026-05-29 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
303 -0.2%
5.01
US$1,518 		303 -0.2% 5.01 US$1,518
2026-05-29 2026-05-28 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
2,989 -1.6%
4.93
US$14,736 		2,989 -1.6% 4.93 US$14,736
2026-05-26 2026-05-22 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,165 -0.6%
5.69
US$6,629 		1,165 -0.6% 5.69 US$6,629
2026-05-29 2026-05-12 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
3,298 -1.8%
5.28
US$17,413 		3,298 -1.8% 5.28 US$17,413
2026-05-29 2026-05-11 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
6,476 -3.3%
5.76
US$37,302 		6,476 -3.3% 5.76 US$37,302
2026-05-11 2026-05-11 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
60,000
5.81
US$348,600 		60,000 5.81 US$348,600
2025-12-31 2025-12-29 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
9,933 -100.0%
6.97
US$69,233 		9,933 -100.0% 6.97 US$69,233
2025-12-29 2025-12-29 PrS Proposed sale
2.3
MATTHEW K SZOT

Officer

Officer
9,933
7.41
US$73,604 		9,933 7.41 US$73,604
2025-10-28 2025-10-27 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,800 -15.3%
13.99
US$25,182 		1,800 -15.3% 13.99 US$25,182
2025-10-28 2025-10-27 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,315 -0.7%
13.99
US$18,397 		1,315 -0.7% 13.99 US$18,397
2025-10-27 2025-10-27 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,800
14.13
US$25,442 		1,800 14.13 US$25,442
2025-10-27 2025-10-27 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
1,315
13.99
US$18,397 		1,315 13.99 US$18,397
2025-10-28 2025-10-24 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,800 -13.3%
13.99
US$25,182 		1,800 -13.3% 13.99 US$25,182
2025-10-28 2025-10-24 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,129 -0.6%
14.03
US$15,840 		1,129 -0.6% 14.03 US$15,840
2025-10-24 2025-10-24 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,800
13.77
US$24,786 		1,800 13.77 US$24,786
2025-10-24 2025-10-24 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
1,129
14.03
US$15,841 		1,129 14.03 US$15,841
2025-10-14 2025-10-13 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,800
13.62
US$24,516 		1,800 13.62 US$24,516
2025-10-14 2025-10-13 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
1,800
14.15
US$25,470 		1,800 14.15 US$25,470
2025-10-14 2025-10-13 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,800 -0.9%
14.15
US$25,470 		1,800 -0.9% 14.15 US$25,470
2025-10-14 2025-10-13 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,800 -11.7%
14.07
US$25,326 		1,800 -11.7% 14.07 US$25,326
2025-10-14 2025-10-09 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,800 -0.9%
14.02
US$25,236 		1,800 -0.9% 14.02 US$25,236
2025-10-14 2025-10-09 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,693 -9.9%
13.99
US$23,685 		1,693 -9.9% 13.99 US$23,685
2025-10-09 2025-10-09 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,693
13.96
US$23,634 		1,693 13.96 US$23,634
2025-10-09 2025-10-09 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
1,800
14.02
US$25,228 		1,800 14.02 US$25,228
2025-10-07 2025-10-06 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
107 -0.6%
13.99
US$1,497 		107 -0.6% 13.99 US$1,497
2025-10-06 2025-10-06 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
107
14.18
US$1,517 		107 14.18 US$1,517
2025-10-03 2025-10-02 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
500 -0.2%
14.13
US$7,065 		500 -0.2% 14.13 US$7,065
2025-10-02 2025-10-02 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
500
14.13
US$7,066 		500 14.13 US$7,066
2025-10-01 2025-10-01 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,700
13.83
US$23,511 		1,700 13.83 US$23,511
2025-10-01 2025-10-01 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
881
14.01
US$12,343 		881 14.01 US$12,343
2025-10-01 2025-10-01 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
881 -0.4%
14.01
US$12,343 		881 -0.4% 14.01 US$12,343
2025-10-01 2025-10-01 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,700 -9.0%
13.99
US$23,783 		1,700 -9.0% 13.99 US$23,783
2025-10-01 2025-09-29 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
419 -0.2%
14.01
US$5,870 		419 -0.2% 14.01 US$5,870
2025-10-01 2025-09-29 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
100 -0.5%
14.00
US$1,400 		100 -0.5% 14.00 US$1,400
2025-09-29 2025-09-29 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
100
14.03
US$1,403 		100 14.03 US$1,403
2025-09-29 2025-09-29 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
419
14.01
US$5,870 		419 14.01 US$5,870
2025-09-29 2025-09-25 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
6,790
14.09
US$95,662 		6,790 14.09 US$95,662
2025-09-26 2025-09-25 S Sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
6,790 -3.2%
14.09
US$95,671 		6,790 -3.2% 14.09 US$95,671
2025-09-26 2025-09-25 S Sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
10,900 -36.5%
14.05
US$153,182 		10,900 -36.5% 14.05 US$153,182
2025-09-25 2025-09-25 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
10,900
13.78
US$150,202 		10,900 13.78 US$150,202
2025-09-26 2025-09-24 S Sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
2,581 -1.2%
13.99
US$36,108 		2,581 -1.2% 13.99 US$36,108
2025-09-26 2025-09-24 S Sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,500 -4.8%
14.00
US$20,993 		1,500 -4.8% 14.00 US$20,993
2025-09-25 2025-09-24 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
6,790
14.09
US$95,662 		6,790 14.09 US$95,662
2025-09-24 2025-09-24 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,500
13.68
US$20,520 		1,500 13.68 US$20,520
2025-09-24 2025-09-24 PrS Proposed sale
2.8
Quang Pham

Officer

Officer
2,581
13.99
US$36,108 		2,581 13.99 US$36,108
2025-08-29 2025-08-28 S Sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,193 -0.6%
13.99
US$16,690 		1,193 -0.6% 13.99 US$16,690
2025-08-29 2025-08-28 S Sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
400 -1.3%
14.00
US$5,600 		400 -1.3% 14.00 US$5,600
2025-08-28 2025-08-28 PrS Proposed sale
2.8
Pham Quang X

Officer

Officer
1,193
13.86
US$16,541 		1,193 13.86 US$16,541
2025-08-28 2025-08-28 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
400
13.93
US$5,572 		400 13.93 US$5,572
2025-08-29 2025-08-27 S Sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
3,836 -1.8%
13.99
US$53,666 		3,836 -1.8% 13.99 US$53,666
2025-08-29 2025-08-27 S Sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,600 -4.8%
14.00
US$22,392 		1,600 -4.8% 14.00 US$22,392
2025-08-27 2025-08-27 PrS Proposed sale
2.8
Pham Quang X

Officer

Officer
3,836
13.94
US$53,456 		3,836 13.94 US$53,456
2025-08-27 2025-08-27 PrS Proposed sale
2.8
Pham Quang X

Officer

Officer
30,600
13.99
US$428,094 		30,600 13.99 US$428,094
2025-08-27 2025-08-27 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,600
13.75
US$22,000 		1,600 13.75 US$22,000
2023-10-06 2023-10-05 B Purchase
2.8
MURPHY JOHN RAYMOND
Non-Executive Director
2,669 +0.4%
0.69
US$1,842 		2,669 +0.4% 0.69 US$1,842
Explore more

More insider trading research around Cadrenal Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America